Suspension of trading

Business Segments Durect

Stocks

DRRX

US2666055007

Market Closed - Nasdaq 01:30:00 11/09/2025 am IST			5-day change	1st Jan Change
1.910 ^USD	-1.04%		-.--%	-

11/25/11	Bausch Health Companies Inc. completed the acquisition of DURECT Corporation.	CI
11/25/11	Bausch Health Completes US$63 Million Durect Acquisition, Adds Breakthrough Hepatitis Therapy to Pipeline	MT

Sales 2024 by Business Segment

© MarketScreener.com See more

Sales 2024 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Geographical Revenue Distribution History

Breakdown by Business Segment (USD)

Fiscal Period: December	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Pharmaceutical Products
Research, Development and Manufacturing of Pharmaceutical Products						3.01Cr	1.4Cr	1.93Cr	85.48L	20.31L
Total Assets						7.56Cr	9.2Cr	6.01Cr	4.52Cr	1.83Cr
Interest Expense						-22.37L	-21.48L	-23.99L	-27.92L	-
Income Tax Expense						-	-	-	-	-
CAPEX						-2L	-2L	-1L	-52T	-
EBT						-1.43Cr	-3.63Cr	-3.53Cr	-2.76Cr	-1.84Cr
D&A						3L	3L	1L	31T	84T
Operating Income						-1.26Cr	-3.43Cr	-3.51Cr	-3.69Cr	-1.89Cr
Net Income						-6L	-3.63Cr	-3.53Cr	-2.76Cr	-83.24L

Geographical breakdown of sales (USD)

Fiscal Period: December	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Europe						13.86L	66.3L	1.18Cr	23L	15.92L
Others						7L	6L	6L	10.72L	2L
United States						2.69Cr	56.9L	54.47L	46.17L	2L
Japan						11.74L	10.15L	14.88L	6L	-

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

-40%: Exceptional extension

SEIZE THE OFFER!